A pharmaceuticals health care company.
P.L. 112-144, The Food and Drug Administration Safety and Innovation Act of 2012.
  
Federal legislative efforts to enhance the security and integrity of the domestic pharmaceutical distribution system. H.R. 6446: To create incentive for innovative diagnostics by improving the process for determining Medicare payment rates for new tests. H.J.Res. 117: Continuing Appropriations Resolution for Fiscal Year 2013.
HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX